# Medtech Convergence Fund, L.P. — Form D

Medtech Convergence Fund, L.P. of BOSTON, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-03-12. The offering totals $94.0M. Industry: Pooled Investment Fund.

## Offering

- Filed: 2019-03-12
- Form: D
- Accession: 0001770396-19-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $94.0M
- Remaining: $94.0M
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-334664

## Issuer

- Name: Medtech Convergence Fund, L.P.
- CIK: 0001770396
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: ONE BOSTON PLACE, BOSTON, MA, 02108
- Phone: 617-367-8100

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Paul LaViolette | Executive Officer | Seattle, WA |
| N/A Medtech Convergence GP LLC | Executive Officer | Boston, MA |
| Aaron Sandoski | Executive Officer | Bedford, MA |

## More

- [CIK 1770396 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1770396&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001770396-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.